Neoantigen peptide mimics
AssigneeJanssen Biotech, Inc.
InventorsVinod Krishna, Manuel Alejandro Sepulveda, Vipul Bhargava, Iqbal S. Grewal, Kurtis Bachman
Life of this patent
Estimating the term…
Loading patent…
AssigneeJanssen Biotech, Inc.
InventorsVinod Krishna, Manuel Alejandro Sepulveda, Vipul Bhargava, Iqbal S. Grewal, Kurtis Bachman
Estimating the term…
Disclosed herein are polypeptide fragments and polynucleotides based on mutant capicua transcriptional repressor (CIC), catenin beta 1 (CTNNB1), v-erb-b2 erythroblastic leukemia viral oncogene homolog B (ERBB2), kirsten rat sarcoma (KRAS), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), phosphatase and tensin homolog (PTEN), splicing factor 3b subunit 1 (SF3B1), SRY-box transcription factor 17 (SOX17), tumor protein 53 (TP53), and cytomegalovirus (CMV) sequences, vectors, host cells, viruses, methods for generating CD8+ T-cells, and methods of treatment. Also disclosed herein are T-cell receptors (TCRs), polynucleotides, vectors and cells comprising the TCRs, and methods of treatment.
A polynucleotide encoding at least one or more polypeptide fragments selected from:
Dependencies are inferred from the claim text.